52 Views
By Howcast
215 Views
6 Views
By VideoJug
81 Views
By VideoJug
54 Views
By VideoJug
How To Be A Qualified Clinical Psychologist
5 Views
By VideoJug
93 Views
By VideoJug
2,775 Views
By explore.org
Prostate Cancer Blood Test Risky: Study
10 Views
By CBS
New Study: Which Drinks Lead to Weight Gain?
5 Views
By CBS
The Blood Red Mountain Band @ Rouge Rock, April...
22 Views
By Muzu
Heart Patient Sees Results in Stem Cell Study
7 Views
By CBS
Cereal Study Shows Worst Sugar Offenders
5 Views
By CBS
28 Views
By AnyClip
47 Views
By CBS
From Human Skin to Blood Cells
41 Views
By CBS
Birth Control Pills and Blood Clots
18 Views
By CBS
P.S.A. Blood Test Reliability in Question
6 Views
By CBS
30 Views
By AnyClip
Blood Diamond (2006): My Son Will Be a Doctor
18 Views
By AnyClip
David E Sugar at Bestival 2010 - David E Sugar...
10 Views
By Muzu
00:56
Lucky Number Slevin (2006): Borrowing Sugar
169 Views
By AnyClip
04:00
50 Views
By VideoJug
Thrash Hits TV: Rock Sugar @ Download Festival...
21 Views
By Muzu
01:36
354 Views
By watchmojo
01:55
95 Views
By FilmTrailer
01:55
267 Views
By FilmTrailer
01:55
71 Views
By FilmTrailer
01:50
High-Definition
How to Reduce Your Sugar Intake [HD]
30 Views
By Howcast
01:51
Blood Diamond (2006): Training Child Soldiers
184 Views
By AnyClip
Add video views to your Facebook Timeline:
Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-daily liraglutide when taken alone produced statistically significant improvement in blood sugar (glucose) control in patients with type 2 diabetes, as compared to glimepiride, a widely used oral anti-diabetic drug (OAD).
In addition, liraglutide demonstrated the following benefits compared to glimepiride:
-Statistically significant reduction in body weight
-Statistically significant reduction in risk of hypoglycemia
-Statistically significant reduction in systolic blood pressure
In this 12-month study, 62% of patients treated with liraglutide who had not been previously treated with diabetes medications achieved an average reduction in blood sugar that brought them below the ADA target for HbA1c of 7%.
To view Multimedia News release go to, http://www.prnewswire.com/mnr/novonordisk/33424/